La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Madison Square Garden a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Madison Square Garden..

Madison Square Garden (NYSE:MSGE) Azioni, Catena delle Opzioni

MADISON SQUARE GARDEN ENTERT

Madison Square Garden

Madison Square Garden Entertainment Corp provides live entertainment, delivering unforgettable experiences while forging deep connections with diverse and passionate audiences. The company's portfolio includes a collection of world-renowned venues - New York's Madison Square Garden, The Theater at Madison Square Garden, Radio City Music Hall, and Beacon Theatre; and The Chicago Theatre - that showcase a broad array of sporting events, concerts, family shows, and special events for millions of guests annually. In addition, the company features the original production, the Christmas Spectacular Starring the Radio City Rockettes, which has been a holiday tradition for 89 years.

Madison Square Garden Entertainment Corp. Class A Common Stock

Madison Square Garden Entertainment Corp

The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Noble Corporation PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NE#NYSE">NE</a>)</h3>
<ul>
<li>On April 7, Barclays analyst Eddie Kim maintained Noble Corp with an Overweight rating and lowered the price target from $39 to $29. The company's stock fell around 19% over the past five days and has a <a href="https://www.benzinga.com/quote/NE">52-week low of $17.40</a>.</li>
<li>RSI Value: 29.2</li>
<li>NE Price Action: Shares of Noble gained 5.4% to close at $19.41 on Monday.</li>
<li>Edge Stock Ratings: 8.25 Momentum score with Value at 93.03. </li>
</ul>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/ne"><img loading="lazy" decoding="async" width="412" height="171" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08030815/image-28.png" alt="" class="wp-image-861266" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08030815/image-28.png 412w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08030815/image-28-300x125.png 300w" sizes="(max-width: 412px) 100vw, 412px" /></a></figure>
<h3 class="wp-block-heading">Seadrill Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SDRL#NYSE">SDRL</a>)</h3>
<ul>
<li>On March 19, Citigroup analyst Scott Gruber maintained Seadrill with a Buy rating and lowered the price target from $46 to $35. The company's stock fell around 20% over the past month and <a href="https://www.benzinga.com/quote/SDRL">has a 52-week low</a> of $18.25.</li>
<li>RSI Value: 27.3</li>
<li>SDRL Price Action: Shares of Seadrill gained 4.4% to close at $20.08 on Monday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0408">SDRL stoc</a>k. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><img loading="lazy" decoding="async" width="930" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08030900/image-29.png" alt="" class="wp-image-861268" style="width:534px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08030900/image-29.png 930w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08030900/image-29-300x270.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08030900/image-29-768x691.png 768w" sizes="(max-width: 930px) 100vw, 930px" /></figure>
<h3 class="wp-block-heading">Nabors Industries Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBR#NYSE">NBR</a>)</h3>
<ul>
<li>On March 27, Morgan Stanley analyst Daniel Kutz maintained Nabors Industries with an Overweight rating and lowered the price target from $115 to $75. The company's stock fell around 28% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/NBR">low of $26.23.</a></li>
<li>RSI Value: 25.8</li>
<li>NBR Price Action: Shares of Nabors Industries gained 3.1% to close at $29.86 on Monday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0408">NBR shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0408"><img loading="lazy" decoding="async" width="867" height="831" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08031003/image-30.png" alt="" class="wp-image-861269" style="width:491px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08031003/image-30.png 867w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08031003/image-30-300x288.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/08031003/image-30-768x736.png 768w" sizes="(max-width: 867px) 100vw, 867px" /></a></figure>
BZ Edge Rankings: Find out where other stocks stand—<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">explore the full comparison now</a>.
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/04/44669062/top-3-health-care-stocks-that-may-crash-in-q2">Top 3 Health Care Stocks That May Crash In Q2</a> </li>
<li></li>
</ul>
Photo via Shutterstock

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

SDRL

Top 3 Energy Stocks You'll Regret Missing In Q2

JP Morgan analyst Bryan Smilek downgrades Chegg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) from Neutral to Underweight.

Downgrades

Analyst Ratings

CHGG

JP Morgan Downgrades Chegg to Underweight

Contracts

V2X Awarded $62M Contract To Support COBRA DANE Radar Operational Readiness Through 2027

General

KIDZ

KIDZW

Classover Announces Development Of A Next-Generation Artificial Intelligence Powered Tutoring Platform

JP Morgan analyst Matthew Boss upgrades Levi Strauss (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) from Neutral to Overweight and lowers the price target from $19 to $17.

Upgrades

Price Target

LEVI

JP Morgan Upgrades Levi Strauss to Overweight, Lowers Price Target to $17

Needham analyst Ami Fadia reiterates Blueprint Medicines (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPMC#NASDAQ">BPMC</a>) with a Buy and maintains $133 price target.

Reiteration

BPMC

Needham Reiterates Buy on Blueprint Medicines, Maintains $133 Price Target

JP Morgan analyst Richard Shane upgrades Essent Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESNT#NYSE">ESNT</a>) from Neutral to Overweight and maintains the price target from $60 to $60.

ESNT

JP Morgan Upgrades Essent Group to Overweight, Maintains Price Target to $60

Management

Harley-Davidson's Board Of Directors Confirm On-Going CEO Search Process

As global markets continue to swing wildly in the aftermath of Trump's tariffs coming into play, an old observation from Berkshire Hathaway&#8217;s former vice-chair, <a href="https://www.benzinga.com/25/04/44659224/billionaire-charlie-munger-said-hed-be-the-richest-man-on-earth-if-he-could-go-back-100-years-and-start-over-i-could-have-done-a-lot-better">Charlie Munger,</a><a href="https://www.benzinga.com/25/04/44659224/billionaire-charlie-munger-said-hed-be-the-richest-man-on-earth-if-he-could-go-back-100-years-and-start-over-i-could-have-done-a-lot-better"> sounds more relevant than ever</a>. 
What Happened: During volatility, Munger once told shareholders: "The market is not going to do exactly what you want when you want it&#8230;&#8221;
&#8220;I wouldn&#8217;t worry too much about what happens over six months or twelve months. I don&#8217;t think you&#8217;re really all that welcome in this room if the short-term orientation is what turns you on."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Charlie Munger: &quot;The market is not going to do exactly what you want when you want it &#8230; I wouldn&#39;t worry too much about what happens over six months or twelve months. I don&#39;t think you&#39;re really all that welcome in this room if the short-term orientation is what turns you on.&quot; <a href="https://t.co/yQLY20cK4P">pic.twitter.com/yQLY20cK4P</a>
&mdash; Kevin Carpenter (@kejca) <a href="https://twitter.com/kejca/status/1908919285847556486?ref_src=twsrc%5Etfw">April 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/personal-finance/financial-advisors/25/04/44680547/dave-ramsey-caller-asks-if-they-should-stop-contributing-during-market-collapse-ten-years-from-now-you-wont-even-remember-this-crap">Dave Ramsey Caller Asks If They Should Stop Contributing During Market Collapse — &#8216;Ten Years From Now You Won&#8217;t Even Remember This Crap&#8217;</a>
Why It Matters: Trump's sweeping tariffs have triggered a <a href="https://www.benzinga.com/general/market-summary/25/04/44679853/wall-street-eyes-recovery-as-sp-500-nasdaq-futures-rise-after-trumps-tariff-driven-selloff-wipes-out-9-trillion-in-six-weeks">market meltdown, wiping out $9 trillion</a> in just six weeks—an impact rivaling the losses seen during the peak of the COVID-19 crash and surpassing the year-long decline following the 2008 Lehman Brothers collapse, according to Bear Traps Report founder Lawrence McDonald.
On Monday, stocks swung as investors responded to contradictory signals. Hopes that tariffs might be halted for a bit pushed the S&amp;P 500 almost 7% from its recent low, only for the market to change course when the Trump administration confirmed the 25% hike on Chinese goods would go ahead. <a href="https://www.benzinga.com/news/global/25/04/44679330/will-trump-impose-higher-tariffs-on-china-crypto-bettors-now-see-an-80-possibility">China threatened retaliation, leading to a fresh wave of uncertainty</a>. By evening, futures for the Dow, S&amp;P 500, and Nasdaq-100 had each climbed by more than 1%.

The recent episode underscores just how reactive markets have become—bouncing on speculation, then falling on confirmation. <a href="https://www.benzinga.com/markets/25/04/44657195/charlie-munger-slams-teaching-stock-trading-to-young-people-its-like-trying-to-induce-young-people-to-start-off-on-heroin">Munger's lesson highlights the danger of chasing headlines</a> and banking on instant gratification from markets that are, by nature, unpredictable.
At a time when even experienced investors are tempted to time the chaos, <a href="https://www.benzinga.com/personal-finance/25/04/44654791/billionaire-charlie-munger-hated-being-told-what-to-do-he-said-getting-rich-meant-you-could-say-to-hell-with-them-and-avoid-needing-anyone">Munger's reminder</a> stands steady: patience beats panic, particularly when the noise is loudest.
Image via Shutterstock
Read Next: <a href="https://www.benzinga.com/25/04/44681272/jim-cramer-questions-market-strength-amid-chinas-retaliatory-tariffs-oversold-panic-or-a-big-trap">Jim Cramer Cautions Against Jumping In As Oversold Market Sparks Futures Rebound Without Clear Catalyst: &#8216;Is It All A Big Trap?&#8217;</a>

Equities

Charlie Munger Once Said, 'The Market Won't Do Exactly What You Want, When You Want' — As Tariff Jitters And Wild Swings Remind Investors Why Long-Term Thinking Matters

JP Morgan analyst Richard Shane upgrades Guild Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHLD#NYSE">GHLD</a>) from Underweight to Neutral and lowers the price target from $12.5 to $12.

GHLD

JP Morgan Upgrades Guild Holdings to Neutral, Lowers Price Target to $12

Health Care

KURA

Kura Oncology Submits New Drug Application (NDA) To The FDA For ziftomenib For The Treatment Of Acute Myeloid Leukemia (AML)

JP Morgan analyst Jimmy Bhullar upgrades RenaissanceRe Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RNR#NYSE">RNR</a>) from Neutral to Overweight and maintains the price target from $284 to $284.

JP Morgan Upgrades RenaissanceRe Holdings to Overweight, Maintains Price Target to $284

Biotech

Financing

Offerings

IBRX

ImmunityBio Announced Registered Direct Offering Of Approximately $75M In Gross Proceeds With A Single Institutional Investor, If Fully Exercised, The Warrants Could Result In Additional Gross Proceeds Of Up To Approximately $90M

JP Morgan analyst Jimmy Bhullar upgrades Palomar Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLMR#NASDAQ">PLMR</a>) from Neutral to Overweight and raises the price target from $115 to $150.

PLMR

JP Morgan Upgrades Palomar Hldgs to Overweight, Raises Price Target to $150

ZENA

ZenaTech Scales Domestic Drone Production For Commercial And Defense Markets Without Raising Prices

Dividends

SIGA

SIGA Technologies Declared A Special Cash Dividend Of $0.60 Per Share Payable On May 15, 2025, To Shareholders Of Record At The Close Of Business On April 29, 2025

GXAI

Gaxos.ai Launches AI-Enabled Gaxos Health Mobile Application For iOS And Android

HC Wainwright &amp; Co. analyst Mitchell Kapoor reiterates Lexeo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEO#NASDAQ">LXEO</a>) with a Buy and maintains $23 price target.

LXEO

HC Wainwright & Co. Reiterates Buy on Lexeo Therapeutics, Maintains $23 Price Target

<ul>
<li>Since providing initial guidance, the Company received larger than expected orders during the final week of March, and has also obtained additional visibility into inventory levels on hand at some of our current purchasing customers. Based on this new information, CorMedix is increasing its H1 2025 guidance for Net Sales to existing purchasing customers to a revised range of $62 million to $70 million.</li>
<li>While the Company is currently forecasting net sales from existing purchasing customers in 2Q 2025 to be lower than 1Q 2025, this is due to the timing of shipments to those customers between quarters, and does not suggest an anticipated decrease in patient utilization in the second quarter or the second half of 2025. CorMedix currently forecasts patient utilization with existing purchasing customers to continue to grow throughout 2025 as implementation expands to new patients, and currently anticipates unit shipments in H2 2025 to exceed shipments in H1 2025.</li>
<li>CorMedix expects patient enrollment for our Phase 3 study of DefenCath in patients receiving Total Parenteral Nutrition, or TPN, to begin in late April. The Company believes DefenCath, if approved for this indication, can achieve peak annual sales in this patient population of $150 million to $200 million, with a total addressable market opportunity of $500 million to $750 million.</li>
<li>Cash and short-term investments, excluding restricted cash, at March 31, 2025 amounted to approximately $77.5 million</li>
</ul>

Earnings

Guidance

CRMD

CorMedix Announces Preliminary Revenue Of $39M For 1Q 2025 Vs. Consensus Of $32.20M, And Expects 1Q 2025 Adjusted EBITDA (To Exceed $22.5M Once Final Numbers Are Reported)

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is increasingly behaving like a <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44627407/gold-overtaking-bitcoin-in-inflation-hedge-strategy-jpmorgan-says">high-volatility, liquid version of gold</a>, according to Bernstein analysts.
What Happened: In a note to clients on Tuesday, the analysts wrote that despite falling roughly 26% amid <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44680723/despite-tariff-turmoil-bitcoin-outperforms-magnificent-7-stocks-in-2025-records-smaller-losses-than-nvidia-tesla-apple">ongoing tariff disruptions</a> and geopolitical volatility, Bitcoin has performed better than expected in historical context—especially compared to past market shocks like COVID or rate hike cycles, which triggered 50–70% drawdowns.
The asset&#8217;s resilience during recent global market stress signals a shift toward higher-quality capital and growing institutional adoption, making it a "more liquid and higher-volatility version of gold."
"Bitcoin on a time-scale is probabilistic gold," the note read. "It trades like the most accessible and liquid risk-market when equities are closed, acting as a weekend signal for investor sentiment."
Bernstein&#8217;s report suggests that while Bitcoin has not fully decoupled from traditional equities—and still correlates with risk-on assets—it is increasingly being treated as a long-term store of value. 
The cryptocurrency&#8217;s market capitalization now approaches $2 trillion, still a fraction of gold's $20 trillion market, but it offers greater liquidity and twice the volatility.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44672506/blackrock-ceo-larry-fink-warns-many-already-believe-the-us-is-in-a-recession">BlackRock CEO Larry Fink Warns &#8216;Many Already Believe The US Is In A Recession&#8217;</a>
Why It Matters: Institutional adoption is driving this shift.
Spot Bitcoin ETFs have collectively seen inflows of around $770 million year-to-date despite recent price declines. 
Additionally, large corporate holders such as Strategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) are <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44671650/strategy-reports-59-billion-in-unrealized-bitcoin-losses-pauses-new-purchases">investing with longer-term horizons</a>, with BTC now comprising significant portions of balance sheets across publicly traded firms.
"The ETF flows are still in positive territory and reflect higher-quality capital," the analysts noted, adding that nearly 10% of Bitcoin's total supply is now held in ETFs and corporate treasuries combined.
While macro headwinds like tariffs on China-based mining hardware could impact Bitcoin mining capacity in the short term, U.S. miners such as Riot (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>), CleanSpark (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>) and Core Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) are pivoting to AI infrastructure to diversify revenue streams and withstand geopolitical shocks.
Bernstein&#8217;s core thesis remains that Bitcoin's volatility, liquidity, and emerging role in institutional portfolios are cementing its evolution as a digital commodity asset—distinct from gold, but increasingly a peer in investor strategy.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44670129/bitcoin-whipsaws-as-trillions-in-market-value-are-erased-on-fake-tariff-pause-rumor">Bitcoin Whipsaws As Trillions In Market Value Are Erased On Fake Tariff Pause Rumor</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

CLSK

Core Scientific, Inc. - Class A Common Stock

CORZ

MSTR

RIOT

Bitcoin Is A 'More Liquid And Higher Volatility Version Of Gold': Bernstein

Entertainment

Press Releases

'EXPERIENCE ABU DHABI' NAMED OFFICIAL NEW YORK KNICKS PATCH PARTNER

Madison Square Garden Entertainment Corp. to Host Fiscal 2025 First Quarter Conference Call

MADISON SQUARE GARDEN ENTERTAINMENT CORP. REPORTS FISCAL 2025 FIRST QUARTER RESULTS

Madison Square Garden Entertainment Corp. Repurchases $25 Million of MSGE Class A Common Stock

WATERLOO SPARKLING WATER NAMED AN OFFICIAL PARTNER OF THE NEW YORK RANGERS AND MADISON SQUARE GARDEN

Madison Square Garden Entertainment Corp. to Host Fiscal 2025 Second Quarter Conference Call

MADISON SQUARE GARDEN ENTERTAINMENT CORP. REPORTS FISCAL 2025 SECOND QUARTER RESULTS

THE MSG FAMILY OF COMPANIES AND PEPSICO EXPAND MULTI-YEAR PARTNERSHIP

THE RADIO CITY ROCKETTES CELEBRATE 100 YEARS OF PRECISION, ATHLETICISM & SISTERHOOD IN 2025

THE MSG FAMILY OF COMPANIES ANNOUNCE INTEGRATED MARKETING PARTNERSHIP WITH LIQUID DEATH

MSGE

MSGS

SPHR

AMC Entertainment Holdings, Inc. Class A Common Stock

AMC Entertainment Hldgs

Atlanta Braves Holdings, Inc. - Series A Common Stock

Atlanta Braves Holdings

Atlanta Braves Holdings, Inc. - Series C Common Stock

Cinemark Holdings Inc Cinemark Holdings, Inc. Common Stock

Cinemark Holdings

Walt Disney

Liberty Media Corporation - Series A Liberty Formula One Common Stock

Liberty Media

Ordinary Shares (New Liberty Formula One) Series A

Liberty Media Corporation - Series C Liberty Formula One Common Stock

Ordinary Shares (New Liberty Formula One) Series C

iQIYI

Lions Gate Entertainment Corporation Class A Voting Shares

Lions Gate Entertainment Corporation Class B Non-Voting Shares

Lionsgate Studios

Liberty Media Corporation - Series A Liberty Live Common Stock

Liberty Live

Ordinary Shares (New Liberty Live) Series A

Liberty Media Corporation - Series C Liberty Live Common Stock

Ordinary Shares (New Liberty Live) Series C

Live Nation Entertainment, Inc. Common Stock

Live Nation Entertainment

Manchester United Ltd. Class A Ordinary Shares

Manchester United

Marcus

Madison Square Garden Sports Corp. Class A Common Stock (New)

Netflix

Roku

Reservoir Media

Sphere Entertainment Co. Class A Common Stock

Sphere Entertainment

TKO Group Holdings, Inc. Class A Common Stock

TKO Group Holdings

Tencent Music Entertainment Group American Depositary Shares, each representing two Class A Ordinary Shares

Comments

Madison Square Garden

Madison Square Garden (MSGE) Opzioni

Madison Square Garden (NYSE:MSGE) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO